Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pain 5Vomiting 2Nausea 2Stomach Neoplasms 1Prostatic Neoplasms 1Neoplasm Metastasis 1Mucositis 1Mesothelioma, Malignant 1Lung Neoplasms 1Intraoperative Complications 1Head and Neck Neoplasms 1Fatigue 1Esophageal Neoplasms 1Depression 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenocarcinoma of Lung 1Adenocarcinoma Of Esophagus 1Abnormalities, Radiation-Induced 1

Interventions

Cisplatin 6Pemetrexed 4Carboplatin 3Nivolumab 2Ipilimumab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1ranpirnase 1raltitrexed 1durvalumab 1atezolizumab 1Vinorelbine 1Vincristine 1Talc 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Psychiatric Rehabilitation 1Platinum 1Mitomycin 1Injections 1Gemcitabine 1Fentanyl 1Drug Therapy 1Doxorubicin 1Cerebral Decortication 1Analgesia 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Mesothelioma, Malignant × Analgesia × Clear all
NCT00075699 2013-08-07

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 3 Completed
840 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡